Global Pharmacovigilance and Drug Safety Software Market 2019-2023

SKU ID :TNV-14416294 | Published Date: 26-Jun-2019 | No. of pages: 121
PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY END-USER Market segmentation by end-user Comparison by end-user Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 Contract research organization - Market size and forecast 2018-2023 Business process outsourcing - Market size and forecast 2018-2023 Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES Market drivers Market challenges PART 11: MARKET TRENDS Integration of AI in pharmacovigilance Outsourcing pharmacovigilance and drug safety research to CROs Extensive adoption of cloud technologies in pharmaceutical manufacturing and testing PART 12: VENDOR LANDSCAPE Overview Landscape disruption PART 13: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors AB Cube ArisGlobal LLC Ennov EXTEDO GmbH Oracle Corp. PART 14: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO Exhibit 01: Global healthcare market Exhibit 02: Segments of global healthcare market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: End-user - Market share 2018-2023 (%) Exhibit 18: Comparison by end-user Exhibit 19: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%) Exhibit 21: Contract research organization - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Contract research organization - Year-over-year growth 2019-2023 (%) Exhibit 23: Business process outsourcing - Market size and forecast 2018-2023 ($ millions) Exhibit 24: Business process outsourcing - Year-over-year growth 2019-2023 (%) Exhibit 25: Market opportunity by end-user Exhibit 26: Customer landscape Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 36: ROW - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: AB Cube - Vendor overview Exhibit 46: AB Cube - Business segments Exhibit 47: AB Cube - Organizational developments Exhibit 48: AB Cube - Key offerings Exhibit 49: ArisGlobal LLC - Vendor overview Exhibit 50: ArisGlobal LLC - Product segments Exhibit 51: ArisGlobal LLC - Organizational developments Exhibit 52: ArisGlobal LLC - Key offerings Exhibit 53: Ennov - Vendor overview Exhibit 54: Ennov - Business segments Exhibit 55: Ennov - Organizational developments Exhibit 56: Ennov - Key offerings Exhibit 57: EXTEDO GmbH - Vendor overview Exhibit 58: EXTEDO GmbH - Business segments Exhibit 59: EXTEDO GmbH - Organizational developments Exhibit 60: EXTEDO GmbH - Key offerings Exhibit 61: Oracle Corp. - Vendor overview Exhibit 62: Oracle Corp. - Business segments Exhibit 63: Oracle Corp. - Organizational developments Exhibit 64: Oracle Corp. - Geographic focus Exhibit 65: Oracle Corp. - Segment focus Exhibit 66: Oracle Corp. - Key offerings Exhibit 67: Validation techniques employed for market sizing Exhibit 68: Definition of market positioning of vendors
AB Cube ArisGlobal LLC Ennov EXTEDO GmbH Oracle Corp.
  • PRICE
  • $2500
    $4000
    Buy Now

Our Clients